Cargando…
Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia
BACKGROUND: Acute promyelocytic leukaemia (APL) is a unique subtype of acute myeloid leukaemia (AML) characterized by haematopoietic failure caused by the accumulation of abnormal promyelocytic cells in bone marrow (BM). However, indispensable BM biopsy frequently afflicts patients in leukaemia surv...
Autores principales: | Wang, Guiran, Yan, Guiling, Sang, Kanru, Yang, Huijie, Sun, Ni, Bai, Yuanyuan, Xu, Feng, Zheng, Xiaoqun, Chen, Zhanguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059359/ https://www.ncbi.nlm.nih.gov/pubmed/35501730 http://dx.doi.org/10.1186/s12885-022-09621-1 |
Ejemplares similares
-
Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017) -
Role of the promyelocytic leukaemia protein in cell death regulation
por: Salomoni, P, et al.
Publicado: (2012) -
LncRNA LOC105378097 inhibits cardiac mitophagy in natural ageing mice
por: Liu, Xin, et al.
Publicado: (2022) -
Extramedullary disease in acute promyelocytic leukaemia: A rare presentation
por: Kasinathan, Ganesh, et al.
Publicado: (2020) -
Genome-wide functions of PML–RARα in acute promyelocytic leukaemia
por: Saeed, S, et al.
Publicado: (2011)